This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Prospective Clinical Evaluation of ASR/Re-Cap Resurfacing Arthroplasty

This study has been completed.
Sponsor:
Information provided by:
Frederiksberg University Hospital
ClinicalTrials.gov Identifier:
NCT00376610
First received: September 14, 2006
Last updated: July 3, 2007
Last verified: July 2007
  Purpose
ASR/Re-cap versus 28 MoM

Condition Intervention Phase
Bearings Device: ASR/Re-cap Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Prospective Clinical Evaluation of ASR/Re-Cap Resurfacing Arthroplasty

Further study details as provided by Frederiksberg University Hospital:

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Clinical diagnosis of THA
  • ASA I-II
  • Willing to return for follow-up evaluations

Exclusion Criteria:

  • Collum femurs < 2 cm
  • Cysts > 1 cm
  • Caput necrose
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00376610

Locations
Denmark
Frederiksberg University Hospital
Frederiksberg, Copenhagen, Denmark, 2000
Sponsors and Collaborators
Frederiksberg University Hospital
Investigators
Study Director: Arne Borgwardt Frederiksberg Univesity Hospital
  More Information

ClinicalTrials.gov Identifier: NCT00376610     History of Changes
Other Study ID Numbers: KF1127957
Study First Received: September 14, 2006
Last Updated: July 3, 2007

ClinicalTrials.gov processed this record on August 18, 2017